Resumen:
The Yucca genus encompasses about 50 species native to North America. Species within
the Yucca genus have been used in traditional medicine to treat pathologies related to inflammation.
Despite its historical use and the popular notion of its antioxidant and anti-inflammatory
properties, there is a limited amount of research on this genus. To better understand these properties,
this work aimed to analyze phytochemical composition through documentary research. This
will provide a better understanding of the molecules and the mechanisms of action that confer
such antioxidant and anti-inflammatory properties. About 92 phytochemicals present within the
genus have reported antioxidant or anti-inflammatory effects. It has been suggested that the antioxidant
and anti-inflammatory properties are mainly generated through its free radical scavenging
activity, the inhibition of arachidonic acid metabolism, the decrease in TNF- (Tumor necrosis
factor- ), IL-6 (Interleukin-6), iNOS (Inducible nitric oxide synthase), and IL-1 (Interleukin 1 )
concentration, the increase of GPx (Glutathione peroxidase), CAT (Catalase), and SOD (Superoxide
dismutase) concentration, and the inhibition of the MAPK (Mitogen-Activated Protein Kinase), and
NF- B (Nuclear factor kappa B), and the activation of the Nrf2 (Nuclear factor erythroid 2–related
factor) signaling pathway. These studies provide evidence of its use in traditional medicine against
pathologies related to inflammation. However, more models and studies are needed to properly
understand the activity of most plants within the genus, its potency, and the feasibility of its use to
help manage or treat chronic inflammation.